Drug Profile
Protein therapy - Unknown
Latest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Unknown
- Class Amino acids; Peptides; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Unspecified in Japan
- 04 Oct 2016 An undisclosed Japanese global pharmaceutical company enter into a contract manufacturing agreement with Ajinomoto for the development of protein therapy
- 04 Oct 2016 Phase-I clinical trials in Undefined indication in Japan (unspecified route)